Pursuant to Regulation 74(5) of the SEBI (Depository & Participants) Regulations, 2018, Bafna Pharmaceuticals has informed that it enclosed certificate dated July 07, 2023, received from Cameo Corporate Services, the Registrar and Share Transfer Agent (RTA) of the Company, confirming the dematerialization of share certificate during the quarter ended June 30, 2023.
The above information is a part of company’s filings submitted to BSE.